ArticleFrontiers in neurology
Prefrontal cortex activation patterns in age-related cognitive decline: insights from verbal fluency task.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Age-related cognitive decline (ARCD) is highly prevalent in aging populations and is characterized by progressive declines in cognitive function-particularly executive function (EF), which merits focused investigation. This study aimed to compare prefrontal cortex (PFC) activation patterns between ARCD patients with executive dysfunction (ED) and those with non-executive dysfunction (non-ED) using functional near-infrared spectroscopy (fNIRS) during a verbal fluency task (VFT). It further explored correlations between alterations in PFC activation, the severity of EF impairment, and global cognitive function. Methods: A total of 36 elderly individuals diagnosed with ARCD were recruited for this study. Participants were stratified into the ED group or the non-ED group based on neuropsychological test performance, with 18 individuals in each group. fNIRS was employed during the VFT to assess cortical activity. Additionally, a comprehensive neuropsychological assessment was conducted to evaluate global cognitive function, as well as specific domains related to memory and EF. Correlations between PFC activation, as reflected by changes in oxyhemoglobin (oxy-Hb) concentration and cognitive outcomes were analyzed. Results: The participants of the ED group were older than those in the non-ED group, and had a higher incidence of type 2 diabetes mellitus than those in the non-ED group. The fNIRS-VFT analysis revealed no activation of the PFC in the ED group ( Conclusion: ARCD showed attenuated PFC activation during VFT, with no significant difference between the ED and non-ED groups. The decline in PFC activation was correlated with lower MoCA scores, suggesting that fNIRS-derived PFC activation metrics might serve as a potential biomarker for global cognitive decline in ARCD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.